Interferon-beta plus ribavirin for patients with hepatitis C virus genotype 1: a randomised pilot trial.
Enomoto
M
M
Tamori
A
A
Kawada
N
N
Jomura
H
H
Nishiguchi
S
S
Saibara
T
T
Onishi
S
S
Mochida
S
S
Fujiwara
K
K
D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use; D016899:Interferon-beta / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010865:Pilot Projects; D011994:Recombinant Proteins; D012254:Ribavirin / Q000627:therapeutic use*; D016896:Treatment Outcome
D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D012254:Ribavirin; D016899:Interferon-beta